Evidence map›Paper›PMID 41340841›Full record

ReviewJMIR XR and spatial computing2025

Virtual Reality Reminiscence Therapy in Dementia Care: Scoping Review of Research.

Maria Matsangidou

Abstract readReview
In one paragraph

Review in JMIR XR and spatial computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Maria MatsangidouCYENS Centre of Excellence, Lellou Demetriades, Plateia Dimarchou 1, Nicosia, 1016, Cyprus, 357 22 747575.ORCID https://orcid.org/0000-0003-3804-5565

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dementia is a progressive neurological disorder affecting cognitive and social functioning, posing challenges for patients and caregivers. Traditional medications often have adverse effects, emphasizing the need for nonpharmacological options such as reminiscence therapy (RT). Virtual reality (VR) has emerged as a promising tool in dementia care, providing immersive experiences that stimulate memory, enhance emotional well-being, and reduce the behavioral and psychological symptoms of dementia. Objective: This scoping review assesses the feasibility and implementation challenges of delivering RT via VR in dementia care. Specifically, it examines the types of VR systems used, their therapeutic benefits, and the barriers to their adoption. Methods: We screened 5 electronic libraries: Google Scholar, ACM Digital Library, IEEE Xplore, MEDLINE, and PubMed. Studies published between 2000 and 2025 were included if they examined the use of VR for RT in people with dementia. Data were charted based on PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines and analyzed thematically for feasibility, VR system type, therapeutic effects, and implementation considerations. Results: A total of 15 studies met the inclusion criteria. The findings indicate that VR is feasible and well-accepted among people with dementia, fostering high engagement with minimal adverse effects. Fully immersive VR systems, which use head-mounted displays, are the most frequently used, while semi-immersive alternatives with large screens provide a more cost-effective option. RT via VR has been shown to improve reminiscence, enhance mood, and encourage social interaction. However, its impact on cognitive function remains inconclusive. Significant barriers to implementation include high costs, limited availability of VR infrastructure in care, and the need for specialized caregiver training. Conclusions: RT via VR presents a promising advancement in dementia care. Future research should focus on developing cost-effective, scalable VR solutions, designing personalized VR experiences tailored to individual needs, and creating structured training programs for caregivers. Longitudinal studies are necessary to determine the long-term therapeutic effects of VR compared to traditional RT.

Indexed as

cognitive stimulationdementiaemotional stimulationnonpharmacological interventionsreminiscence therapyvirtual reality

Identifiers

PMID41340841
PMCPMC12671293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.